Get the Stockscreener App
0.00
2.94%
-0.102
Neximmune Inc stock is traded at $0.00, with a volume of 0.
It is down -2.94% in the last 24 hours and down -22.22% over the past month.
See More
Previous Close:
$0.102
Open:
$0
24h Volume:
0
Relative Volume:
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
$-20.62M
P/E Ratio:
0.00
EPS:
-18.54
Net Cash Flow:
$-17.61M
1W Performance:
-2.94%
1M Performance:
-22.22%
6M Performance:
-74.07%
1Y Performance:
+623.57%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$0.00
Neximmune Inc Stock (NEXI) Company Profile
Compare NEXI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NEXI
Neximmune Inc
|
0.00 | 0 | 0 | -20.62M | -17.61M | -18.54 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.15 | 100.34B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
585.50 | 60.95B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.73 | 60.46B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
734.35 | 46.04B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
332.20 | 36.02B | 3.81B | -644.79M | -669.77M | -6.24 |
Neximmune Inc Stock (NEXI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-01-21 | Initiated | Raymond James | Outperform |
| Mar-09-21 | Initiated | Barclays | Overweight |
| Mar-09-21 | Initiated | Cantor Fitzgerald | Overweight |
Neximmune Inc Stock (NEXI) Latest News
Nasdaq supports reforms to reduce burden on public companies, CEO Friedman says - MarketScreener
Amatuhi Holdings Incannounces IPO of 1,000,000 sharesSEC filing - MarketScreener
Tctm Kids It Educationchanges name to VisionSys AI Inc - MarketScreener
Nasdaq notches record high close, traders look to Fed meeting - MarketScreener
Riku Dining Group Ltd sees U.S. IPO of 2.3 million Class A ordinary shares - MarketScreener
Blockchain lender Figure valued at $7.6 billion as shares jump in Nasdaq debut - MarketScreener
LB Pharma shares rise 27% in Nasdaq debut, bring valuation to about $382 million - MarketScreener
LB Pharmaceuticals raises $285 million in US IPO - MarketScreener
S&P, Nasdaq notch record-high closes as Oracle soars on AI optimism - MarketScreener
Zenta Group Company Closes $6 Million IPO - MarketScreener
Pelican (PELI) to merge with Greenland Exploration & March GL, forming Greenland Energy Company - MarketScreener
E-commerce firm Pattern eyes up to $2.6 billion valuation in US IPO - MarketScreener
Hama Intelligence Ltd sees US IPO of 1.1 million class A ordinary shares - MarketScreener
Exclusive-Stablecoin issuer Figure Technologies set to upsize IPO as demand for crypto-related stocks soars, source says - MarketScreener
Gemini Space Station says Nasdaq agreed to purchase $50 million of company's class A common stock - MarketScreener
Blank check company Evolution Global Acquisition sees IPO of up to $175 million - MarketScreener
Nasdaq notches record high close; traders focus on rate cuts - MarketScreener
CoinShares to Go Public by Merging With SPAC - MarketScreener
Evonexus Group Ltd files for US IPO, offering 2 mln class A ordinary shares - MarketScreener
Data center builder Fermi files for US IPO as new listings accelerate - MarketScreener
CoinShares to List on Nasdaq in the US via SPAC Deal - MarketScreener
FutureCrest Acquisition Corp files for IPO of $250 million - MarketScreener
Optimi Health Corphave applied to list common shares on Nasdaq Capital Market under trading symbol "Opth" - MarketScreener
Lorenzo Developments Incannounces initial public offering of common sharesSEC filing - MarketScreener
Lafayette Acquisition Corp files for IPO of up to $100 mlnSEC filing - MarketScreener
Wall Street indexes end higher as data keeps rate cut views intact - MarketScreener
AlphaTON Capital Establishes Specialized Digital Asset Treasury Company; Appoints Brittany Kaiser as CEO - MarketScreener
Cell Expansion: Market Insights & 2032 Segmentation Focused on Terumo BCT Developments - newstrail.com
Global Health Solutions Incto change name to Turn TherapeuticsSEC filing - MarketScreener
Blackstone-backed Legence targets nearly $3 billion valuation in US IPO - MarketScreener
Starboard Commits to Share Lock-Up Ahead of Maha's Dual Listing in the US - MarketScreener
Crypto Weekly: the Trump's dominate - MarketScreener
S&P, Nasdaq Rise Ahead of Nvidia Earnings | Closing Bell - MarketScreener
Top Premarket Decliners - MarketScreener
What's Driving the Red-Hot IPO Market - MarketScreener
Netskope Inc announces IPO of Class A common stock - MarketScreener
Australia's Zip soars on strong earnings, outlook, US listing plan - MarketScreener
Tech Down as AI Stock Wobble Continues -- Tech Roundup - MarketScreener
FGFR Inhibitors Market Set to Surge by 2034 as Targeted Cancer Therapies Transform Treatment Paradigms | DelveInsight - The Malaysian Reserve
Blockchain lender Figure Technology reveals revenue surge in US IPO filing - MarketScreener
Blank check company Talon Capital Corp files for IPO of up to $225 million - MarketScreener
Warburg Pincus-backed Miami International raises $345 million in US IPO - MarketScreener
McKinley Acquisition Prices $150 Million IPO - MarketScreener
Firefly Aerospace sputters a day after stellar Nasdaq debut - MarketScreener
Heartflow raises $316.7 million in US IPO as medtech listings attempt comeback - MarketScreener
Apple Surge Boots S&P 500, Nasdaq | Closing Bell - MarketScreener
Boxabl and FG Merger II Corp sign merger agreement to pursue a Boxabl public listing on Nasdaq - MarketScreener
MIAX-parent Miami International targets $1.7 billion valuation in rare exchange IPO - MarketScreener
HCM III Acquisition Prices IPO - MarketScreener
Charming Wow files for U.S. IPO of up to 750,000 shares - MarketScreener
S&P 500 and Nasdaq Hit New Highs | Closing Bell - MarketScreener
Neximmune Inc Stock (NEXI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.62%
0.57%
Cap:
|
Volume (24h):